Soleus Capital Management, L.P. Ionis Pharmaceuticals Inc Transaction History

Soleus Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $890,054 - $1.18 Million	-19,648 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $794,882 - $1.05 Million	-16,752 Reduced 46.02%	19,648 $932,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $1.71 Million - $2.22 Million	36,400 New	36,400 $2.15 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.